Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Health Catalyst Inc before investing.

In this article, we go over a few key elements for understanding Health Catalyst Inc’s stock price such as:

• Health Catalyst Inc’s current stock price and volume
• Why Health Catalyst Inc’s stock price changed recently
• Upgrades and downgrades for HCAT from analysts
• HCAT’s stock price momentum as measured by its relative strength

About Health Catalyst Inc (HCAT)

Before we jump into Health Catalyst Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company?s solutions comprise a cloud-based data platform, software analytics applications, and professional services capabilities. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its customers are primarily healthcare providers.

Want to learn more about Health Catalyst Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Health Catalyst Inc.

Health Catalyst Inc’s Stock Price as of Market Close

As of September 21, 2023, 4:00 PM, CST, Health Catalyst Inc’s stock price was $9.89.

Health Catalyst Inc is down 6.79% from its previous closing price of $10.61.

During the last market session, Health Catalyst Inc’s stock traded between $10.30 and $10.74. Currently, there are 55.98 million shares of Health Catalyst Inc stock available for purchase.

Unfortunately, Health Catalyst Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Health Catalyst Inc Stock Price History

Health Catalyst Inc’s (HCAT) price is currently down 15.4% so far this month.

During the month of September, Health Catalyst Inc’s stock price has reached a high of $12.05 and a low of $9.86.

Over the last year, Health Catalyst Inc has hit prices as high as $15.87 and as low as $6.40. Year to date, Health Catalyst Inc’s stock is down 75.04%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Health Catalyst Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of September 20, 2023,, no analysts have changed their rating of Health Catalyst Inc’s stock over the last month.

Additionally, you'll want to evaluate Health Catalyst Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Health Catalyst Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Health Catalyst Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Health Catalyst Inc (HCAT) by visiting AAII Stock Evaluator.

Relative Price Strength of Health Catalyst Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 20, 2023, Health Catalyst Inc has a weighted four-quarter relative price strength of -3.65%, which translates to a Momentum Score of 51 and is considered to be Average.

Want to learn more about how Health Catalyst Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Health Catalyst Inc Stock Price: Bottom Line

As of September 21, 2023, Health Catalyst Inc’s stock price is $9.89, which is down 6.79% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Health Catalyst Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.